Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Allergy Therapeutics Market & Company News

16.01.2020 12:25 Allergy Therapeutics Trading Update & Notice of Results - Replacement RNS
16.01.2020 09:08 Allergy Therapeutics PLC Allergy Therapeutics revenue up 8%; says grass pollen allergen trial remains 'on track' SMW
16.01.2020 08:00 Hardman & Co Research Allergy Therapeutics (AGY): Sales growth well above market average EQS
16.01.2020 07:00 Allergy Therapeutics Half Year Trading Update & Notice of Results RNS
02.12.2019 09:57 Allergy Therapeutics Holdings in Company RNS
29.11.2019 10:34 Allergy Therapeutics Holdings in Company RNS
26.11.2019 15:01 Allergy Therapeutics PLC Allergy Therapeutics extends planned vaccine study to two stages SMW
26.11.2019 07:00 Allergy Therapeutics Update to Grass MATA MPL Ph III clinical programme RNS
25.11.2019 12:13 Allergy Therapeutics Result of Annual General Meeting RNS
22.10.2019 09:23 Allergy Therapeutics Annual Report and Accounts RNS
26.09.2019 07:30 Hardman & Co Research Allergy Therapeutics (AGY): Continuing to gain market share EQS
25.09.2019 14:47 Allergy Therapeutics PLC Allergy Therapeutics swings to profit on higher sales; lower R&D costs SMW
25.09.2019 07:00 Allergy Therapeutics Preliminary Results RNS
11.07.2019 08:40 Allergy Therapeutics PLC Allergy Therapeutics reiterates guidance on continued market share gain in core European markets SMW
11.07.2019 07:00 Allergy Therapeutics Trading update RNS
01.07.2019 07:20 Hardman & Co Research Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty EQS
01.07.2019 07:15 Hardman & Co Research Oxford BioMedica (OXB): Eying up long-term value EQS
27.06.2019 08:48 Allergy Therapeutics PLC Allergy Therapeutics expects earnings to top market expectatations amid falling costs SMW
27.06.2019 07:00 Allergy Therapeutics Successful Litigation Settlement RNS
27.06.2019 07:00 Allergy Therapeutics Trading Statement RNS
19.06.2019 07:00 Allergy Therapeutics Board Change RNS
11.06.2019 07:00 Allergy Therapeutics Holdings in Company RNS
21.05.2019 08:30 Hardman & Co Research Titon Holdings Plc (TON): You need hands EQS
21.05.2019 07:15 Hardman & Co Research Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress EQS
20.05.2019 09:25 Allergy Therapeutics PLC Allergy Therapeutics says dust mite treatment meets primary objective SMW
20.05.2019 07:00 Allergy Therapeutics Positive top line phase I results for Acarovac MPL RNS
14.05.2019 07:00 Allergy Therapeutics Holdings in Company RNS
13.05.2019 18:14 Allergy Therapeutics Holding(s) in Company RNS
13.05.2019 16:41 Allergy Therapeutics Second Price Monitoring Extn RNS
13.05.2019 16:35 Allergy Therapeutics Price Monitoring Extension RNS
07.05.2019 07:00 Allergy Therapeutics Research Published on Adjuvant Systems RNS
25.04.2019 09:18 Allergy Therapeutics PLC Allergy Therapeutics to launch Phase III trial of allergic rhinoconjunctivitis treatment in 2020 SMW
25.04.2019 07:00 Allergy Therapeutics Regulatory and Trading Update RNS
22.03.2019 08:40 Allergy Therapeutics PLC Broker Forecast - finnCap issues a broker note on Allergy Therapeutics PLC SMW
18.03.2019 16:41 Allergy Therapeutics Second Price Monitoring Extn RNS
18.03.2019 16:36 Allergy Therapeutics Price Monitoring Extension RNS
18.03.2019 11:30 Hardman & Co Research Allergy Therapeutics (AGY): Take an objective view EQS
18.03.2019 11:05 Allergy Therapeutics Second Price Monitoring Extn RNS
18.03.2019 11:00 Allergy Therapeutics Price Monitoring Extension RNS
18.03.2019 09:05 Allergy Therapeutics Second Price Monitoring Extn RNS
18.03.2019 09:00 Allergy Therapeutics Price Monitoring Extension RNS
18.03.2019 08:48 Allergy Therapeutics PLC Allergy Therapeutics birch-pollen allergy treatment fails to meet primary objective SMW
18.03.2019 07:00 Allergy Therapeutics Top Line Phase III results from B301 trial RNS
06.03.2019 14:50 Allergy Therapeutics PLC Allergy Therapeutics profit jumps 68% on higher sales, lower R&D spend SMW
06.03.2019 12:10 Hardman & Co Research Allergy Therapeutics (AGY): Strong operating performance driving market share EQS
06.03.2019 07:00 Allergy Therapeutics Interim Results RNS
17.01.2019 09:56 Hardman & Co Research Allergy Therapeutics (AGY): Trading update: gaining market share EQS
16.01.2019 09:22 Allergy Therapeutics PLC Allergy Therapeutics says trading in line with expectations as revenues rise 10.6% SMW
16.01.2019 07:00 Allergy Therapeutics Trading Update & Notice of Results RNS
29.11.2018 17:59 Allergy Therapeutics Holdings in Company RNS
Showing 1 to 50 of 651